Lecture 9 LRTI (Pneumonia) Flashcards

1
Q

What are clinical Signs of Infection

A
  • inflammation
  • Redness
  • Heat
  • Pus

Systemic Signs; fever, Increased HR, Increased RR, Increased WBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the characteristics of a fever

A

fever most common & most non-specific feature of infection
❑ > 37.5 (oral / armpit) (99.5 oF)
❑ > 38oC (tympanic / rectal) (100.2oF)

  • Very young and Elderly may not respond with a fever
  • HR is increased by 10-15BPm for each 1* increase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are potential results of an untreated fever

A

❑ enhanced leukocyte migration
❑ augmented lymphocyte function
❑ reduced microbial replication
❑ improved survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

White blood count ranges and meanings

A

WBC increased (leukocytes) in most bacterial or fungal infections
Normal ; 4-11
> 11; suspect of infection
> 15-17; very sick
Sepsis- either very low or very high -50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What’s the risk involved with Pneumonia

A

• Those > 65 years of age at greatest risk
• >50% of cases and 90% of mortality in these patients
• Mortality is <1% in outpatients but 14% in those hospitalized
• A viral infection precedes pneumonia in up to 50% of
cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is community acquired Pneumonia (CAP)

A
  • defined as an acute infection of the pulmonary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Blood culture and sensitivity test

A

Should be performed in ill febrile pt’s

Should be taken from two different peripheral sites at least a few minutes to an hour apart from one one another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sputum C&S

A

Usually performed in LRSTI

❑ Specimen quality can be assessed by considering
the relative proportions of the components seen
under the microscope
❑ PMNs
❑ Epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the systemic signs of infection?

A

Fever, increased heart rate (HR), increased respiratory rate (RR), and increased white blood cell count (WBC).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the normal range for white blood cell count (WBC)?

A

4.0-11.0 x 10^9/L (4,000-11,000/mm^3).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a common cause of fever besides infection?

A

Drug fevers, transfusion reactions, lymphoma, or post-myocardial infarction (MI).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the most common bacterial pathogen causing community-acquired pneumonia (CAP)?

A

Streptococcus pneumoniae.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the risk factors for resistant S. pneumoniae?

A

Antibacterial use in the past 3 months, age >65, exposure to children from daycare, alcoholism, and immunosuppression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the typical presentation of Mycoplasma pneumoniae infection?

A

Gradual onset of fever, headache, malaise, followed by a persistent hacking cough, often with non-pulmonary symptoms like nausea, vomiting, and skin rashes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the role of procalcitonin (PCT) in diagnosing bacterial infections?

A

PCT is a biomarker used to predict the likelihood of bacterial infection and can guide antibacterial therapy, especially in respiratory infections and sepsis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 2016 IDSA/ATS guidelines for procalcitonin use in HAP/VAP?

A

Procalcitonin levels plus clinical criteria should be used to guide discontinuation of antibiotic therapy in HAP/VAP (weak recommendation, low-quality evidence).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the clinical signs of pneumonia?

A

Fever >37.8°C, hypothermia, rigors, sweats, new cough with sputum, chest discomfort, dyspnea, and abnormal breath sounds (rales, rhonchi).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the risk factors for poor outcomes in pneumonia?

A

Respiratory rate >30, systolic BP <90, acute renal dysfunction, malnourishment, functional impairment, and leukopenia <4 x 10^9/L.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the CURB-65 score used for?

A

It is a risk assessment tool for community-acquired pneumonia (CAP) to determine the need for hospitalization based on confusion, uremia, respiratory rate, blood pressure, and age >65.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the first-line empiric treatment for outpatient CAP with no comorbidities?

A

Amoxicillin 1 g PO TID or doxycycline 200 mg PO once, then 100 mg PO BID.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the empiric treatment for severe CAP requiring ICU admission?

A

Ceftriaxone 1-2 g IV daily plus azithromycin 500 mg IV/PO daily. If MRSA is suspected, add vancomycin or linezolid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the criteria for clinical stability in pneumonia patients?

A

Temperature ≤37.8°C, heart rate ≤100 bpm, respiratory rate ≤24 breaths/min, systolic BP ≥90 mmHg, O2 saturation ≥90%, ability to maintain oral intake, and normal mental status.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the common pathogens in nursing home-acquired pneumonia (NHAP)?

A

S. pneumoniae, H. influenzae, S. aureus, Enterobacterales, and C. pneumoniae.

24
Q

What is the empiric treatment for late-onset hospital-acquired pneumonia (HAP)?

A

Ceftriaxone 1-2 g IV daily or levofloxacin 750 mg PO/IV daily, plus gentamicin if P. aeruginosa is suspected.

25
Q

What are the prevention strategies for ventilator-associated pneumonia (VAP)?

A

Elevate the head of the bed 30-45°, mouth care, remove NG/ET tubes ASAP, continuous sub-glottic suctioning, and hand hygiene.

26
Q

What are the common pathogens in aspiration pneumonia with risk factors for gut anaerobes?

A

S. pneumoniae, H. influenzae, S. aureus, Enterobacterales, and anaerobes.

27
Q

What is the empiric treatment for aspiration pneumonia with risk factors for gut anaerobes?

A

Amoxicillin/clavulanate or ceftriaxone 1-2 g IV daily plus metronidazole 500 mg IV/PO BID.

28
Q

What is the most common cause of acute bronchitis?

A

Viral infections (≥90% of cases).

29
Q

What is the recommended supportive treatment for acute bronchitis?

A

Increased humidity, smoking cessation, antitussives, and bronchodilators (if needed).

30
Q

What is the mortality rate for outpatients with pneumonia?

A

Less than 1%.

31
Q

What is the mortality rate for hospitalized patients with pneumonia?

A

Approximately 14%.

32
Q

What are the common non-infectious outcomes of pneumonia?

A

Acute cardiac events (e.g., myocardial infarction, atrial fibrillation) and worsening heart failure.

33
Q

What is the Pneumonia Severity of Illness (PSI) scoring system used for?

A

To assess the severity of community-acquired pneumonia (CAP) and guide treatment decisions.

34
Q

What are the common symptoms of Chlamydia pneumoniae infection?

A

Mild respiratory symptoms, fever, headache, and gradual onset, with re-infection common in older adults.

35
Q

What is the typical presentation of Haemophilus influenzae pneumonia?

A

Bronchopneumonia or acute exacerbation in COPD patients, with cough, fever, and pleuritic chest pain.

36
Q

What are the common pathogens in early-onset ventilator-associated pneumonia (VAP)?

A

Enterobacterales, S. pneumoniae, H. influenzae, and S. aureus.

37
Q

What is the empiric treatment for early-onset VAP?

A

Ceftriaxone 1-2 g IV daily or levofloxacin 750 mg IV/PO daily. If MRSA is suspected, add vancomycin or linezolid.

38
Q

What is the empiric treatment for late-onset VAP with risk factors for multidrug-resistant pathogens?

A

Piperacillin/tazobactam 4.5 g IV q6h or meropenem 500 mg IV q6h, plus tobramycin or ciprofloxacin. If MRSA is suspected, add vancomycin or linezolid.

39
Q

What are the common pathogens in aspiration pneumonia without risk factors for gut anaerobes?

A

S. pneumoniae, H. influenzae, S. aureus, and Enterobacterales.

40
Q

What is the empiric treatment for aspiration pneumonia without risk factors for gut anaerobes?

A

Ceftriaxone 1-2 g IV daily or levofloxacin 750 mg IV/PO daily.

41
Q

What are the common symptoms of viral pneumonia?

A

Upper respiratory symptoms, patchy pulmonary infiltrates, and normal or minimally elevated white blood cell count.

42
Q

What is the recommended duration of antibacterial therapy for CAP?

A

Minimum of 3-5 days and until clinically stable.

43
Q

What are the common pathogens in hospital-acquired pneumonia (HAP)?

A

Enterobacterales, P. aeruginosa, S. aureus, and S. pneumoniae.

44
Q

What is the empiric treatment for mild-moderate hospital-acquired aspiration pneumonia?

A

Amoxicillin/clavulanate or ceftriaxone 1-2 g IV daily plus metronidazole 500 mg IV/PO BID.

45
Q

What is the empiric treatment for severe hospital-acquired aspiration pneumonia?

A

Piperacillin/tazobactam 4.5 g IV q6h or meropenem 500 mg IV q6h.

46
Q

What are the common symptoms of influenza pneumonia?

A

Sudden onset of flu-like syndrome, upper respiratory symptoms, and positive diagnostic test for influenza virus.

47
Q

What is the role of macrolides in pneumonia treatment?

A

Macrolides have immunomodulatory effects, suppressing inflammatory cytokines and reducing morbidity and mortality in CAP when added to β-lactams.

48
Q

What are the common symptoms of lobar pneumonia?

A

Sudden onset of fever, chills, cough, and pleuritic chest pain, often with dense consolidation on chest X-ray.

49
Q

What is the recommended follow-up for pneumonia patients?

A

Follow-up chest X-ray at 6 weeks for patients with extensive/necrotizing pneumonia, smoking history, alcoholism, or weight loss.

50
Q

What are the common symptoms of Mycoplasma pneumoniae infection?

A

Gradual onset of fever, headache, malaise, and persistent hacking cough, often with non-pulmonary symptoms like nausea and skin rashes.

51
Q

What is the recommended treatment for acute bronchitis?

A

Supportive care, including increased humidity, smoking cessation, antitussives, and bronchodilators if needed. Antibiotics are not recommended.

52
Q

What is the recommended treatment for Haemophilus influenzae pneumonia?

A

Ceftriaxone 1-2 g IV daily or levofloxacin 750 mg IV/PO daily.

53
Q

What are the common symptoms of Streptococcus pneumoniae pneumonia?

A

Sudden onset of fever, chills, cough, and pleuritic chest pain, often with lobar consolidation on chest X-ray.

54
Q

What is the recommended treatment for Mycoplasma pneumoniae pneumonia?

A

Azithromycin 500 mg PO daily or doxycycline 100 mg PO BID.

55
Q

What are the common symptoms of Chlamydia pneumoniae pneumonia?

A

Mild respiratory symptoms, fever, headache, and gradual onset, with re-infection common in older adults.

56
Q

What is the recommended treatment for Chlamydia pneumoniae pneumonia?

A

Azithromycin 500 mg PO daily or doxycycline 100 mg PO BID.

57
Q

What are the common symptoms of Haemophilus influenzae pneumonia?

A

Bronchopneumonia or acute exacerbation in COPD patients, with cough, fever, and pleuritic chest pain.